UBASH3B and neoplasm: Importantly, while bulk RNA-seq analysis may obscure cell-type-specific contributions, our integrative approach—combining deconvolution (CIBERSORT), single-cell validation, and survival modeling—ensured that UBASH3B’s prognostic value reflects intrinsic tumor biology and functionally critical immune subsets rather than confounding cellular heterogeneity.